Last reviewed · How we verify

NCT03589157

Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial

Status unknown NA Last updated 17 July 2018
What this trial tests

NA trial testing drug-coated balloon (DCB) combined with spot stenting of drug-eluting stent (DES) in Diffuse Coronary Artery Lesions in 140 participants. Status unknown.

Timeline
15 July 2018
Primary endpoint
30 June 2021
30 June 2022

Quick facts

Lead sponsorChinese PLA General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment140
Start date15 July 2018
Primary completion30 June 2021
Estimated completion30 June 2022

Drugs / interventions tested

Conditions studied

Sponsor

Chinese PLA General Hospital

Who can join

Adults 18 to 80, any sex, with Diffuse Coronary Artery Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The prospective, randomized, controlled clinical trial aims to evaluate the safety and efficacy of paclitaxel-eluting PTCA-balloon catheter (SeQuent® Please) combined with provisional spot stenting of DES versus DES for treating diffuse coronary artery lesions concerning interventional therapy and vessel patency.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Contemporary Percutaneous Coronary Intervention in Diabetic Patients.
    Tartaglia F, Filiberti G, Bernardini V, Gitto M, et al · · 2025 · PMID 41524061 · DOI 10.31083/rcm44861

Verify or expand the search:

Other Chinese PLA General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03589157.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing